Pharma stock under Rs 50 ends session in red, shares update on proposed acquisition of US-based firm
Shares of Sudarshan Pharma Industries ended the trading session in the red…
46% YTD return: Pharma stock to be in focus as company announces expansion in US market, details here
Shares of BSE-listed Sudarshan Pharma Industries Limited will be in focus during…
Q3 results: Pharma stock in focus as revenue increases 45% YoY, check share price
The stock's 14-day relative strength index (RSI) is 30.63. For the uninitiated,…
